Recent years have witnessed remarkable advances in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as potential https://orlandoxffe813034.blog-ezine.com/39324002/exploring-the-future-of-type-2-diabetes-treatment-retatrutide-and-trizepatide